Product
Supplier
Encyclopedia
Inquiry
Home > Biochemical Engineering > Polypeptide > Lixisenatide for Sale > Lixisenatide CAS NO. 320367-13-3, 827033-10-3
Lixisenatide CAS NO. 320367-13-3, 827033-10-3 buy - large image1
Lixisenatide CAS NO. 320367-13-3, 827033-10-3 buy - image1

Lixisenatide CAS NO. 320367-13-3, 827033-10-3

1 Inquiries

Unit Price: Get Latest Price
CAS No.:

320367-13-3

Grade:

Research grade

Port:

SHANGHAI

Packaging:

0.001kg/Bottle

Price valid (until):

2020-12-31

Company Type:
Manufactory
Location:
China
Qualification:
Main Products:

Pharmaceutical Peptide,Cosmetic peptide,Custom peptides,API polypeptide,Amino acids and derivatives,Peptide - Teriparatide

  • Product Description

  • Seller Information

  • Inquiry History

  • Description

    Product Name:Lixisenatide

    Synonyms:Lixisenatide Acetate

    CAS No.:320367-13-3, 827033-10-3

    Catalog No.:GT-F029

    Key Specification:

    Appearance:  White powder
    Purity (HPLC) ≥95.0%
    Acetate Content(HPLC)≤12.0%
    Water Content (Karl Fischer) ≤8.0%

    Package:

    Vacuum-packed with aluminum foil bag or transparent bag. 500mg,1g, 10g,50g 100g per package with icebag. Or according to your request. 

    Product Detail

    Lixisenatide is a recombinant DNA produced polypeptide analogue of human glucagon-like peptide-1 (GLP-1) which is used in combination with diet and exercise in the therapy of type 2 diabetes, either alone or in combination with other antidiabetic agents.

    Storage:Cool dry place( Store at -20°C, away from the light)

    Remark:For Research Use Only. Not for human use.

    ECHEMI Editorial Reference
    Lixisenatide is a glucagon-like peptide-1 (GLP-1) receptor agonist that can be used in the treatment of type 2 diabetes mellitus (T2DM). Sequence: His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-Asn-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Ser-Lys-Lys-Lys-Lys-Lys-Lys-NH2.

    Basic Info
    Product Name:

    Lixisenatide

    Other Name:

    lixisenatide;Lixisenatide|Lixisenatide Acetate;Lixisenatide Acetate

    CAS No.:

    320367-13-3

    Molecular Formula:

    C215H347N61O65S

    InChIKeys:

    XVVOERDUTLJJHN-IAEQDCLQSA-N

    Molecular Weight:

    4858.53

    Exact Mass:

    4855.54000

    Categories:

    Polypeptide

    Characteristics
    PSA:

    2090

    XLogP3:

    2.13170

    Research
    Class:

    GLP-1 receptor agonist (exendin-4 derivative, 44-amino-acid peptide)

    Status:

    FDA-approved (Adlyxin 2016) / EU-approved (Lyxumia 2013)

    Mechanism:

    A 44-amino-acid peptide derived from exendin-4 with C-terminal modification (6 Lys residues added). Acts as a GLP-1 receptor agonist with prolonged half-life (~3 hours). Enhances glucose-dependent insulin secretion, suppresses glucagon, and slows gastric emptying.

    EC50 (GLP1R Ic50):

    1.4 nM

    Source:

    DrugBank: DB09343; AbMole product data sheet.

    Clinical Development:

    NCT00922084

    FDA:

    Adlyxin (approved 2016-07-28)

    References
    ChEMBL:

    CHEMBL2108674

    DrugBank:

    DB09343

    PubChem:

    PubChem

    Disclaimer:

    Lixisenatide is FDA-approved as a prescription medicine (Adlyxin) for type 2 diabetes. This listing is for industrial and laboratory research use only. Research-chemical listings on B2B marketplaces are not interchangeable with approved medicines. Confirm CAS, specification, and regulatory pathway with the seller. It is not medical advice, a clinical recommendation, or an approved therapy description.

    Hazard Identification

    Classification of the substance or mixture

    Serious eye damage, Category 1

    Reproductive toxicity, Category 2

    GHS label elements, including precautionary statements

    Pictogram(s)
    Signal word

    Danger

    Hazard statement(s)

    H318 Causes serious eye damage

    H361 Suspected of damaging fertility or the unborn child

    Precautionary statement(s)
    Prevention

    P280 Wear protective gloves/protective clothing/eye protection/face protection/hearing protection/...

    P203 Obtain, read and follow all safety instructions before use.

    Response

    P305+P354+P338 IF IN EYES: Immediately rinse with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.

    P317 Get medical help.

    P318 IF exposed or concerned, get medical advice.

    Storage

    P405 Store locked up.

    Disposal

    P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.

    Other hazards which do not result in classification

    no data available

    Handling and Storage

    Precautions for safe handling

    Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.

    Conditions for safe storage, including any incompatibilities

    Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.

  • Seller Information
    Business Type:

    Manufactory

    Main Products:

    Pharmaceutical Peptide,Cosmetic peptide,Custom peptides,API polypeptide,Amino acids and derivatives,Peptide - Teriparatide

    Location:

    5th Floor, Building 1, No. 600 Yinhai Street, Xiasha Street

    Payment Terms:

    TT against copy of documents

    Average lead Time:

    7

    Total Annual Revenue:

    $10 million-$25 million

    Total Employees:

    51-100

    Year of Establishment:

    2014

    Hangzhou Go Top Peptide Biotech , established in 2014, is a technology-based peptide company and a National High-tech Enterprise located in Hangzhou of China. It is also the governing unit of Peptide Branch of China Biochemical Pharmaceutical Industry Association. 

    The company currently has a peptide research center in Hangzhou, covering an area of 2,000m2 . There are two cooperation plants for peptide commercialization located in Shangyu and Anji of Zhejiang province.  The peptide center has equipped with several complete peptide productions lines, including several large-scale peptide synthesizers and advanced imported HPLC systems with different sizes. We also have GMP standard clean laboratories to meet client’s special needs. The company has passed ISO9001:2015 certification.

    At present, the company has developed more than 40 mature pharmaceutical peptides, with the annual production capacity up to 100 kilograms. With a total of 20,000 custom peptides so far, we can provide the one-stop peptide services from research scale (mg) - pilot scale - commercial production(KGs).


    English web site  https://www.gtpeptide.com

    Products and Services

    1.Custom peptide synthesis, such as Research peptide, Neoantigen peptide, Clinical peptide.

    2.Pharmaceutical peptide development and production.

    3.Peptide CRO and CDMO.

    4. Cosmetic peptide and formulation development.

    5. Special protected amino acids and small molecules.

    6. Commercialized peptide library.

    7. Technical support of new drug development.


    SHELLY HUDirector of sales13735575465sales1@gotopbio.com
       Cindy MeiThe sales manager13588827304sales3@gotopbio.com




  • Inquiry History
    1 Inquiries
    Country Product Purchase Quantity Date Posted
    United Arab Emirates

    Lixisenatide

    5 G Oct 24, 2025
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.